News

We were pleased to have you at the 13th iVis International Users’ Meeting.
The Meeting was focused on the CIPTA® Web application with three dedicated sessions:
- Session 1: Principles, Definitions, Settings, and Web Communication protocol
- Session 2: Customized ray-tracing ablation plans for phakic and pseudo-phakic eyes
- Session 3: Preliminary Outcomes and Live Surgery

iVis’ European Patent EP 1 649 843 relates to an intelligent control of the areal power density delivered by laser systems in corneal surgery.

We are pleased to announce the CE approval on iRes™2, our fastest 2.0Khz excimer laser, empowering the smallest 350um laser micro-spot to execute iVis proprietary full automated, real-time controlled, no-touch, cTen® surgical procedure, maximizing surgical performance and avoiding intra-operative risks.